MJFF GBA1 Parkinson's Disease Research Catalyst Program
Connects United States Parkinson's researchers through the MJFF GBA1 Catalyst Program for precision treatment design and testing.
The Michael J. Fox Foundation GBA1 Parkinson's Disease Research Catalyst Program funds investigator-initiated research into GBA1-associated Parkinson's disease, one of the most common genetic risk factors for the condition. MJFF, which has invested more than $2 billion in PD research since 2000, designed the Catalyst Program specifically to build mechanistic understanding of how GBA1 dysfunction d…
Funds research into GBA1-associated Parkinson's disease, including molecular mechanisms linking GBA1 dysfunction to neurodegeneration, disease modifiers, progression factors, and cell-type or systems-level effects.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see the timeline
Sign up free to see where teams trip up